ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,384, issued on July 8, was assigned to UNIVERSITY OF GEORGIA RESEARCH FOUNDATION INC. (Athens, Ga.).
"Nanoparticles for treating prostate cancer" was invented by Sheba M. J. MohanKumar (Athens, Ga.), Puliyur S. MohanKumar (Athens, Ga.) and Yen-Jun Chuang (Athens, Ga.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Nanoparticles and formulations for treating prostate cancer in a subject are disclosed. The nanoparticles contain a cage, such as a zeolitic imidazolate framework ("ZIF"), a surface modifying agent, a targeting ligand, and an active agent. The surface modifying ligand is attached to the outer surface of the cage and the targeting ligand is e...